C07F 5/05
Cyclic compounds having at least one ring containing boron but no carbon
Official title: Cyclic compounds having at least one ring containing boron but no carbon in the ring
C07F5/05 (Cyclic compounds having at least one ring containing boron but no carbon) appears on 86 US grants and 110 published applications in this corpus.
Search patents in C07F- Granted patents
- 86
- Published applications
- 110
- Assignees
- 73
- Inventors
- 268
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 3 |
| 2010 | 1 | 2 |
| 2011 | 2 | 4 |
| 2012 | 1 | 0 |
| 2013 | 2 | 4 |
| 2014 | 5 | 6 |
| 2015 | 6 | 9 |
| 2016 | 5 | 10 |
| 2017 | 0 | 5 |
| 2018 | 5 | 10 |
| 2019 | 10 | 14 |
| 2020 | 4 | 13 |
| 2021 | 7 | 7 |
| 2022 | 3 | 4 |
| 2023 | 6 | 4 |
| 2024 | 7 | 8 |
| 2025 | 2 | 4 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cross-linking agent for quasi-solid electrolyte, quasi-solid electrolyte comprising same, and secondary battery using same15 Sep 2026US 12,738,538 B2Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University)
- Compound, anti-reflective film including same, and display device30 Jun 2026US 12,668,602 B2Samsung SDI.Co., Ltd.
- Boronic acid derivatives and therapeutic uses thereof30 Dec 2025US 12,509,475 B2Qpex Biopharma, Inc.
- Synthesis of KRAS G12C inhibitor compound11 Nov 2025US 12,466,825 B2Amgen Inc.
- Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof12 Nov 2024US 12,139,503 B2TAE Life Sciences, LLC
- Boronic acid derivatives and therapeutic uses thereof3 Sep 2026US 2026/0258060 A1Qpex Biopharma, Inc.
- Synthesis of kras g12c inhibitor compound25 Dec 2025US 2025/0388579 A1Amgen Inc.
- Synthesis of kras g12c inhibitor compound5 Jun 2025US 2025/0179068 A1Amgen Inc.
- Boronic acid derivatives and therapeutic uses thereof30 Jan 2025US 2025/0034175 A1Qpex Biopharma, Inc.
- Borylated Amino Acid Compositions For Use In Boron Neutron Capture Therapy and Methods Thereof30 Jan 2025US 2025/0034176 A1TAE Life Sciences, LLC
Most cited
By later US patents
- Proteasome inhibitors62US 7,442,830 B1Millenium Pharmaceuticals, Inc. · 2008
- Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists23US 5,130,439 A1992
- Drug delivery porphyrin compositions and methods22US 5,284,831 AThe Regents of the University of California · 1994
- Boronated porphyrin compounds20US 5,149,801 AThe Regents of the University of California · 1992
- Boronated metalloporphyrine and therapeutic methods19US 5,654,423 AThe Regents of the University of California · 1997